United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60760-936_57e8a220-b3c9-f7c8-e063-6294a90a0931
- Product NDC
- 60760-936
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- St. Mary's Medical Park Pharmacy
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251015
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (60760-936-10) · 60760-936-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →